Uncomplicated Urinary Tract Infections in Women
First-Line Status and Efficacy
- The European Association of Urology recommends nitrofurantoin as first-line treatment for uncomplicated cystitis in women, alongside fosfomycin and pivmecillinam 1, 2, 3
- The American College of Physicians recommends nitrofurantoin for 5 days as a primary option for uncomplicated bacterial cystitis in women 4, 5
Recommended Dosing Regimens
- The European Association of Urology guidelines provide multiple acceptable nitrofurantoin formulations, including nitrofurantoin monohydrate or macrocrystals: 100 mg twice daily for 5 days (Macrobid formulation) 6
Advantages Over Alternative Agents
- The American College of Physicians suggests prioritizing nitrofurantoin over fluoroquinolones and trimethoprim-sulfamethoxazole due to resistance rates 4
- Nitrofurantoin has narrow spectrum activity, minimizing collateral damage to normal flora and reducing promotion of multidrug-resistant organisms 6
Critical Contraindications and Limitations
- The European Urology guidelines state that nitrofurantoin should not be used in patients with pyelonephritis or upper UTI, as it does not achieve adequate tissue concentrations for kidney infections 7, 6
- The European Urology guidelines also state that nitrofurantoin should not be used in patients with creatinine clearance <60 mL/min, as inadequate urinary drug concentrations occur with renal impairment 6
Diagnostic Approach
- The European Urology guidelines suggest that urine culture is not necessary before initiating empiric nitrofurantoin therapy for typical uncomplicated cystitis with classic symptoms 2, 6
Special Considerations for Recurrent UTIs
- The European Urology guidelines recommend that for women with recurrent UTIs, nitrofurantoin can be used for prophylaxis when non-antimicrobial interventions have failed 8, 6